These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12127888)

  • 1. Studies of pervasive toxic contaminants in children: staying the ethical course.
    Mushak P
    Neurotoxicol Teratol; 2002; 24(4):463-5. PubMed ID: 12127888
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric research and the federal minimal risk standard.
    Ross LF; Nelson RM
    JAMA; 2006 Feb; 295(7):759; author reply 759-60. PubMed ID: 16478898
    [No Abstract]   [Full Text] [Related]  

  • 3. Confronting the ethical challenges of environmental health research.
    Ryan D; Farr N
    Neurotoxicol Teratol; 2002; 24(4):471-3. PubMed ID: 12127890
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical studies and the average American kid.
    Weiss R
    Washington Post; 2005 Aug; ():A5. PubMed ID: 16138447
    [No Abstract]   [Full Text] [Related]  

  • 5. Nontherapeutic research, minimal risk, and the Kennedy Krieger lead abatement study.
    Nelson RM
    IRB; 2001; 23(6):7-11. PubMed ID: 12737175
    [No Abstract]   [Full Text] [Related]  

  • 6. Appropriate risk exposure in environmental health research. The Kennedy-Krieger lead abatement study.
    Nelson RM
    Neurotoxicol Teratol; 2002; 24(4):445-9. PubMed ID: 12127884
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethical challenges in conducting pediatric environmental health research. Introduction.
    Bellinger DC; Dietrich KN
    Neurotoxicol Teratol; 2002; 24(4):443. PubMed ID: 12127883
    [No Abstract]   [Full Text] [Related]  

  • 8. Why we need legal standards for pediatric research.
    Wendler D; Forster H
    J Pediatr; 2004 Feb; 144(2):150-3. PubMed ID: 14760251
    [No Abstract]   [Full Text] [Related]  

  • 9. What conditions justify risky nontherapeutic or "no benefit" pediatric studies: a sliding scale analysis.
    Kopelman LM
    J Law Med Ethics; 2004; 32(4):749-58. PubMed ID: 15807363
    [No Abstract]   [Full Text] [Related]  

  • 10. Pediatric research: what is broken and what needs to be fixed?
    Lantos JD
    J Pediatr; 2004 Feb; 144(2):147-9. PubMed ID: 14760250
    [No Abstract]   [Full Text] [Related]  

  • 11. Research on environmental health interventions: ethical problems and solutions.
    Resnik DB; Zeldin DC; Sharp RR
    Account Res; 2005; 12(2):69-101. PubMed ID: 16220621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products.
    van Gerven J; Bonelli M
    Br J Clin Pharmacol; 2018 Jul; 84(7):1401-1409. PubMed ID: 29451320
    [No Abstract]   [Full Text] [Related]  

  • 13. The lead-based paint abatement repair and maintenance study in Baltimore: historic framework and study design.
    Pollak J
    J Health Care Law Policy; 2002; 6(1):89-108. PubMed ID: 15017953
    [No Abstract]   [Full Text] [Related]  

  • 14. When "risk" and "benefit" are open to interpretation--as is generally the case.
    Spriggs M
    Am J Bioeth; 2007 Mar; 7(3):17-9. PubMed ID: 17366223
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary on the Kennedy Krieger Institute Lead Paint Repair and Maintenance Study.
    Pinder L
    Neurotoxicol Teratol; 2002; 24(4):477-9. PubMed ID: 12127892
    [No Abstract]   [Full Text] [Related]  

  • 16. Children as subjects in nontherapeutic research. Grimes v. Kennedy Krieger Institute, Inc.
    Pearce M
    J Leg Med; 2002 Sep; 23(3):421-36. PubMed ID: 12230814
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-beneficial pediatric research and the best interests standard: a legal and ethical reconciliation.
    Litton P
    Yale J Health Policy Law Ethics; 2008; 8(2):359-420. PubMed ID: 19049018
    [No Abstract]   [Full Text] [Related]  

  • 18. "What is legal is not necessarily ethical": the limits of law and drug-testing programs.
    Luna E
    Am J Bioeth; 2004; 4(1):41-3. PubMed ID: 15035947
    [No Abstract]   [Full Text] [Related]  

  • 19. The participation of children in nontherapeutic diabetes research in the US.
    Ross LF
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):378-9. PubMed ID: 17452965
    [No Abstract]   [Full Text] [Related]  

  • 20. Going beyond parents and institutional review boards in protecting children involved in nontherapeutic research.
    Rubinstein E
    Gold Gate Univ Law Rev; 2003; 33(2):251-94. PubMed ID: 15164740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.